Sichuan Goldstone Asia Pharmaceutical Inc.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Sichuan Jinshi Asia Pharmaceutical Co., Ltd. (securities abbreviation "Jinshi Asia Pharmaceutical", securities code "300434") was listed on the Shenzhen Stock Exchange Growth Enterprise Board in 2015. Through decades of industry accumulation and extensive development, it has now become a comprehensive listed company covering research, production, and sales of pharmaceutical health, new materials, and mechanical equipment. Jinshi Yayao has a development history of over 60 years. The pharmaceutical sector of Jinshi Asia Pharmaceutical, formerly known as Hainan Asia Pharmaceutical Co., Ltd., was founded in 1962. After decades of accumulation, it has become a comprehensive research, production, and sales enterprise with a comprehensive business scope covering the fields of medicine, health, and food health. The company has established production bases covering a total area of over 300 acres in Zhejiang and Hainan provinces. It has 18 various subsidiaries. Including multiple pharmaceutical production companies that have passed the national GMP certification, multiple pharmaceutical sales companies that have passed the national GSP certification, multiple drug sales chain terminals that have passed the GSP certification and obtained the qualification of designated retail pharmacies for medical insurance, raw material pharmaceutical manufacturing companies that have obtained the registration document for the production of raw material calcium carbonate issued by the National Food and Drug Administration, and Hangzhou municipal incubator platform that has passed the three-star standard and operation certification of Chinese green building Entities such as research and development innovation centers with zero defects verified by the US FDA and national GMP; The main varieties of medicine cover chemical pharmaceutical preparations, raw materials, and intermediates; Traditional Chinese medicine preparations and medicinal herbs; Multiple fields such as plant extraction and calcium and vitamin mineral health foods. In terms of chemical pharmaceutical preparations, the company actively expands its varieties in the fields of respiration, digestion, orthopedics, and pediatrics. The company is the brand founder and owner of domestic cold medicine frontline products "KuaiKe" and "XiaoKuaiKe". For many years, the company has focused on building product lines covering areas such as cold clearing heat, gastrointestinal digestion, throat clearing and cough relieving, antibacterial and anti-inflammatory, and nutritional supplements. In terms of raw materials and intermediates, the company has national certification qualifications and research and development, production, and sales capabilities in the fields of amantadine hydrochloride and raw material calcium carbonate. The three main varieties, including raw material calcium carbonate, food additive calcium carbonate, and compound food additive calcium carbonate particles, are widely used in the production of calcium preparation products and pharmaceutical excipients. In the field of extracting ginsenoside RH2 from plants, the company has (multiple) patented technologies and produces and sells high-quality health foods from the Jinxing series. In summary, the company's main products currently include three series of 73 varieties: KuaiKe, XiaoKuaiKe series of chemical drugs, JinXing series of ginseng extracts and calcium and vitamin mineral supplements, and KuaiKe herbal series of traditional Chinese medicine decoction pieces. The core variety of KuaiKe cold medicine series has been occupying the position of being the most popular and ranked first variety of cold chemical drugs in China for many years, and is in a relatively stable leading position in the cold medicine track. Jinshi Yayao's new materials and mechanical equipment sector started its business in 2004 and has three new material machinery subsidiaries. In the past 20 years, we have always adhered to the concept of promoting development through technology, and through deep research and development, we have become an absolute technology leader and service provider in the specialized subdivision field of new material machinery and equipment. The main products include the research and application of steel reinforced plastic composite pipeline technology, the research and manufacturing of vacuum coating equipment, and the promising market prospects for vertical circulation three-dimensional parking garages. The company advocates and pursues a state of freedom, health, and happiness in life, hoping to create warmth and happiness in public life through tireless technological exploration. To this end, the company always adheres to the vigorous spirit of openness, exploration, and innovation, focusing on meeting customer needs, embracing industry change and seizing development opportunities, and continuously exploring innovation and progress. |
| Headquarter | Chengdu |
| Establish Date | 7/15/2004 |
| Listed Code | 300434.SZ |
| Listed Date | 4/24/2015 |
| Chairman | Wei Baokang. |
| CEO | Wei Baokang. |
| Website | www.goldstone-group.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
